Treatment via oral midodrine in a patient with prolonged hypotension following carotid artery stenting: a case report.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
09 Feb 2022
Historique:
received: 21 05 2021
accepted: 13 01 2022
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 11 2 2022
Statut: epublish

Résumé

Hypotension and bradycardia are common hemodynamic complications following carotid artery stenting in patients with carotid artery stenosis. Intravenous fluid resuscitation and inotropes such as dopamine are conventional treatments for post-carotid artery stenting hypotension. However, in case of resistant hypotension, there is no clear treatment method. In this report, while intravenous fluid and inotropes did not resolve the patient's hypotension, oral midodrine treated post-carotid artery stenting hypotension. In this report, we present an 82-year-old Caucasian man complaining of a single episode of unilateral visual loss. The patient had left internal carotid artery stenosis and underwent carotid artery stenting. After the procedure, he developed prolonged post-carotid artery stenting hypotension, which was resistant to intravenous fluids and inotropes but immediately showed a promising response to oral midodrine. Oral midodrine can be considered in treatment of post-carotid artery stenting hemodynamic complications.

Sections du résumé

BACKGROUND BACKGROUND
Hypotension and bradycardia are common hemodynamic complications following carotid artery stenting in patients with carotid artery stenosis. Intravenous fluid resuscitation and inotropes such as dopamine are conventional treatments for post-carotid artery stenting hypotension. However, in case of resistant hypotension, there is no clear treatment method. In this report, while intravenous fluid and inotropes did not resolve the patient's hypotension, oral midodrine treated post-carotid artery stenting hypotension.
CASE PRESENTATION METHODS
In this report, we present an 82-year-old Caucasian man complaining of a single episode of unilateral visual loss. The patient had left internal carotid artery stenosis and underwent carotid artery stenting. After the procedure, he developed prolonged post-carotid artery stenting hypotension, which was resistant to intravenous fluids and inotropes but immediately showed a promising response to oral midodrine.
CONCLUSION CONCLUSIONS
Oral midodrine can be considered in treatment of post-carotid artery stenting hemodynamic complications.

Identifiants

pubmed: 35135599
doi: 10.1186/s13256-022-03270-5
pii: 10.1186/s13256-022-03270-5
pmc: PMC8826674
doi:

Substances chimiques

Midodrine 6YE7PBM15H

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

67

Informations de copyright

© 2022. The Author(s).

Références

Stroke. 2010 Jun;41(6):1294-7
pubmed: 20431077
Stroke. 2011 Aug;42(8):e464-540
pubmed: 21282493
J Physiol. 2003 Nov 15;553(Pt 1):3-11
pubmed: 14528027
Drugs. 1984;28 Suppl 2:1-15
pubmed: 6098436
J Vasc Surg. 2005 Jun;41(6):956-61
pubmed: 15944593
Cochrane Database Syst Rev. 2020 Feb 25;2:CD000515
pubmed: 32096559
BMJ Case Rep. 2014 Jan 09;2014:
pubmed: 24408939
J Vasc Surg. 2021 Mar;73(3):975-982
pubmed: 32707379
J Cardiovasc Pharmacol Ther. 2008 Jun;13(2):94-7
pubmed: 18495904
Neurosurgery. 2005 Sep;57(3):472-7; discussion 472-7
pubmed: 16145525
Cochrane Database Syst Rev. 2004;(2):CD000515
pubmed: 15106153
Stroke. 1999 Dec;30(12):2513-6
pubmed: 10582970
Interv Neuroradiol. 2006 Jan 20;12(Suppl 1):205-10
pubmed: 20569633
Catheter Cardiovasc Interv. 2003 Apr;58(4):516-23
pubmed: 12652504
AJNR Am J Neuroradiol. 2008 Nov;29(10):1942-7
pubmed: 18719034
J Am Coll Cardiol. 2006 Apr 18;47(8):1538-43
pubmed: 16630988
BMC Anesthesiol. 2017 Mar 21;17(1):47
pubmed: 28327122

Auteurs

Yaser Jenab (Y)

Fellowship of Interventional Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Kaveh Hosseini (K)

Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Seyed-Mohammad Abtahi-Eivary (SM)

Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. m.abtahi95@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH